Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.37
-1.28 (-3.59%)
At close: May 13, 2025, 4:00 PM
34.41
+0.04 (0.12%)
Pre-market: May 14, 2025, 8:23 AM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $1.97 billion as of May 14, 2025. Its market cap has increased by 18.53% in one year.
Market Cap
1.97B
Enterprise Value
1.64B
1-Year Change
18.53%
Ranking
Category
Stock Price
$34.37
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.97B, an increase of 328.10%. That is a compound annual growth rate of 35.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 1.97B | 0.57% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | 2.06B | 346.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.51B |
| Johnson & Johnson | 361.18B |
| AbbVie | 331.25B |
| Novo Nordisk | 292.03B |
| UnitedHealth Group | 291.72B |
| Abbott Laboratories | 227.41B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |